Structure via PubChem · Public domain (PubChem)
Forodésine
Sign in to saveAlso known as BCX-1777, BCX1777, Fodosine® (proposed trade name), immucillin H, immucillin-H, (2R,3R,4S,5S)-2-(hydroxymethyl)-5-(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-3,4-diol, Forodesine, (1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol
composé chimique
In the Vinony graph
Vinony's link graph records 5 inbound references to Forodésine, and connects out to digital object identifier, chemical formula and molar mass.
It is catalogued under topics including Chemical pages without DrugBank identifier, Drugs missing an ATC code and Drugs with no legal status.
Vinony links it to 8 Wikipedia language editions.
Chemical data
- Formula
- C11H14N4O4
- Molecular weight
- 266.25 g/mol
- IUPAC name
- 7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one
- SMILES
- C1=C(C2=C(N1)C(=O)N=CN2)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
- InChIKey
- IWKXDMQDITUYRK-KUBHLMPHSA-N
- XLogP
- -2.3
- Polar surface area
- 130 Ų
- H-bond donors
- 6
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2017
- Indications
- B-cell acute lymphoblastic leukemia, chronic lymphocytic leukemia, leukemia, lymphoma
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 266.102
Show 4 more facts
- chemical formula
- C₁₁H₁₄N₄O₄
- isomeric SMILES
- C1=C(C2=C(N1)C(=O)N=CN2)[C@H]3[C@@H]([C@@H]([C@H](N3)CO)O)O
- canonical SMILES
- C1=C(C2=C(N1)C(=O)N=CN2)C3C(C(C(N3)CO)O)O
- Commons category
- Immucillin H
Sources (2)
via Wikidata · CC0
Article · Français
La forodésine (DCI) ou immucilline H est un composé organique de structure proche des nucléosides à base purique. C'est un médicament expérimental utilisé dans le traitement ciblé des hémopathies malignes, en particulier la leucémie lymphoblastique aiguë (LAL). Elle fait partie des inhibiteurs de la PNP. Développée par les laboratoires , elle est en 2008 en phase II des essais cliniques.
Abstract from DBpedia / Wikipedia · CC BY-SA